MEDTRONIC PLANS TO SEPARATE ITS DIABETES BUSINESS INTO A STAND-ALONE, PUBLICLY TRADED COMPANY- WSJ
Source text: https://tinyurl.com/yhd34zsa
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.